See also this year's filing and all EDGAR filings for this company.
PDF Report 0001124105_2016_GYRE_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001124105, GYRE Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 68,698,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 698,000 |
| 3 | remainder_Assets | 125,000 |
| 4 | LiabilitiesCurrent | 37,756,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 340,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,533,850 |
| 9 | ResearchAndDevelopmentExpense | 9,060,626 |
| 10 | remainder_Expenses | 3,131,742 |
| 11 | remainder_Revenues | 27,193 |
| 12 | remainder_NetIncome | 2,216,312 |
| 13 | remainder_ComprehensiveNetIncome | -27,460 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 69,521,000 |
| 1 | Liabilities | 38,096,000 |
| 2 | Expenses | 21,726,218 |
| 3 | Revenues | 27,193 |
| 4 | StockholdersEquity | 31,425,000 |
| 5 | NetIncome | -19,482,713 |
| 6 | ComprehensiveNetIncome | -19,496,443 |
| 7 | BaseVar | 65,807,092 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.911 |
| 9 | EconomicCapitalRatio | 2.23 |
Edgar->Model Mapping
Feature Distribution
Change over Time
